Do Non-profit Hospitals Deserve Their Tax Break?
If non-profit hospitals wanted to, they could easily eliminate medical debt for more than 18 million people — just with the money that they should be, but are not, spending…
Blog
Issue
Initiative
Charting a New Path Forward: A Health System Shaped By and Accountable to All People
Charting a New Path Forward: A Health System Shaped By and Accountable to All People
Executive Director Emily Stewart on Community Catalyst’s strategic vision to create a health system rooted in race equity and health justice, and a society where health is a right for…
Pharma’s End Run on Medicaid Spending Controls Hits Consumer and Congressional Opposition
Earlier this month, Community Catalyst joined other national organizations calling on the Obama administration to change the direction of economic treaty negotiations that could impact cost containment by federal and…
Vermont shows the way on Physician Payment Sunshine Act enforcement
Recent action by the Vermont Attorney General’s office to enforce its longstanding law on industry relationships with providers serves as a valuable roadmap for CMS' enforcement of PPSA.
New Resources to Find Affordable Medications
As patients and consumers, we face more and more choices about our health care each year. We all support consumer empowerment in decisions about their care, but consumers don’t always…
White House: Ending Pay-for-Delay Pharma Deals Would Save Americans $11 Billion
While the White House’s budget plan includes some Medicare benefit cuts, such as raising premiums for Part B and Part D, it includes some policy proposals to help lower drug…
Paying for Delay – Putting Consumers in the Crosshairs
As we discussed here last week, the U.S. Supreme Court is currently deliberating over whether pharmaceutical companies can collude to reap $3.5 billion a year in excess profits from American…
SCOTUS Raises Consumer Impact in Arguments on Delayed Generic Drugs
Today, the U.S. Supreme Court heard oral arguments in a lawsuit about a drug company’s ability to pay a competitor to keep a generic drug off the market—so-called “pay-for-delay” settlements….
Delay of Generics Hurts Consumer and Taxpayer Wallets and Patient Health
This spring, the U.S. Supreme Court faces several decisions that will impact millions of people: legal challenges to the Defense of Marriage Act (DOMA) and the Voting Rights Act, for…
Cross Post: Consumers, Doctors and Legislators: Let the Sunshine In
This entry was originally posted on Community Catalyst's PostScript blog. Consumer advocates, doctors, employers and leaders in Congress alike have all written letters this month urging the Centers for Medicare…
Page 1 of 3